Denise will lead the company’s marketing strategy and report directly to chief executive officer Mark Stephenson.
Denise joins Reframe Cancer with experience across financial services, insurance and energy sectors, having previously led marketing functions at Royal London, Scottish Provident, Bright Grey, British Friendly Society and Scottish Power.
She will be responsible for communicating Reframe’s evidence and outcome data, demonstrating its expertise across the cancer care pathway, and enhancing brand awareness across its customer base. Denise’s appointment follows several recent senior hires at Reframe Cancer, including Russell Young as commercial director, Professor Ben Kelly — formerly of Nuffield Health — as chief operating officer, and Nikki Cannon, who previously led the transformation of personalised care and survivorship at Guy’s and St Thomas’ NHS Trust, as head of screening.
Denise Wond, marketing director at Reframe Cancer, commented:
“I'm absolutely thrilled to join the Reframe team and to shape our marketing strategy as we go forward into a period of sustained growth. I know how difficult it is to navigate life with cancer, and I'm honoured to be part of a team that does such a fantastic job in helping people through that journey.”
Mark Stephenson, CEO at Reframe Cancer, added:
“We're delighted to have secured someone of Denise's calibre. Her background in the insurance, financial services and energy sectors speaks for itself. She is the perfect person to bring her passion and expertise to the role and communicate the amazing difference we make for cancer patients for our customers and partners. She will lead the communication of our evidence, data and clinical excellence and solutions that sets Reframe Cancer apart from others.”
